Article Details

Hematological Malignancies Drugs Market Size Unleashed: Igniting 13.7% CAGR Growth by 2031

Retrieved on: 2024-06-28 19:49:31

Tags for this article:

Click the tags to see associated articles and topics

Hematological Malignancies Drugs Market Size Unleashed: Igniting 13.7% CAGR Growth by 2031. View article details on hiswai:

Excerpt

Monoclonal Antibodies. Blincyto (Blinatumomab); Besponsa (Inotuzumab Ozogamicin); Lumoxiti (Moxetumomab Pasudotox); Mylotarg (Gemtuzumab Ozogamicin) ...

Article found on: www.whatech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo